K
Karen A. Hill
Publications - 4
Citations - 7467
Karen A. Hill is an academic researcher. The author has contributed to research in topics: Myocardial infarction & Statin. The author has an hindex of 4, co-authored 4 publications receiving 7362 citations.
Papers
More filters
Journal ArticleDOI
Intensive versus moderate lipid lowering with statins after acute coronary syndromes.
Christopher P. Cannon,Eugene Braunwald,Carolyn H. McCabe,Daniel J. Rader,Jean L. Rouleau,Rene Belder,Steven V. Joyal,Karen A. Hill,Marc A. Pfeffer,Allan M. Skene +9 more
TL;DR: Among patients who have recently had an acute coronary syndrome, an intensive lipid-lowering statin regimen provides greater protection against death or major cardiovascular events than does a standard regimen.
Journal ArticleDOI
Addition of Clopidogrel to Aspirin and Fibrinolytic Therapy for Myocardial Infarction with ST-Segment Elevation
Marc S. Sabatine,Christopher P. Cannon,C. Michael Gibson,Jose Lopez-Sendon,Gilles Montalescot,Pierre Theroux,Marc J. Claeys,Frank Cools,Karen A. Hill,Allan M. Skene,Carolyn H. McCabe,Eugene Braunwald +11 more
TL;DR: A substantial proportion of patients receiving fibrinolytic therapy for myocardial infarction with ST-segment elevation have inadequate reperfusion or reocclusion of the infarct-related artery, leading to an increased risk of complications and death as discussed by the authors.
Journal Article
Addition of clopidogrel to aspirin and fibrinolytic therapy for myocardial infarction with ST-segment elevation
Marc S. Sabatine,Christopher P. Cannon,C. Michael Gibsonn,Jose Lopez-Sendon,Gilles Montalescot,Pierre Theroux,Marc J. Claeys,Frank Cools,Karen A. Hill,Allan M. Skene,Carolyn H. McCabe,Eugene Brauwald +11 more
TL;DR: In patients 75 years of age or younger who have myocardial infarction with ST-segment elevation and who receive aspirin and a standard fibrinolytic regimen, the addition of clopidogrel improves the patency rate of the infarct-related artery and reduces ischemic complications.
Journal ArticleDOI
Comparison of intensive and moderate lipid lowering with statins after acute coronary symptoms
Christopher P. Cannon,Eugene Braunwald,Carolyn H. McCabe,Daniel J. Rader,Jean L. Rouleau,Rene Belder,Steven V. Joyal,Karen A. Hill,Marc A. Pfeffer,Allan M. Skene +9 more
TL;DR: Among patients who have recently had an acute coronary syndrome, an intensive lipidlowering statin regimen provides greater protection against death or major cardiovascular events than does a standard regimen.